357 filings
Page 7 of 18
8-K
pihf1tpc
16 Sep 16
Departure of Directors or Certain Officers
12:00am
8-K
ttykthytvvzvv
25 Aug 16
Results of Operations and Financial Condition
12:00am
8-K
36sml
17 Aug 16
Departure of Directors or Certain Officers
12:00am
8-K
mwekh3rq75un3ncs
9 Aug 16
ImmunoGen Announces Departure of Chief Development Officer
12:00am
8-K
ny87ege0
4 Aug 16
ImmunoGen Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Provides Quarterly Business Update
12:00am
8-K
f4jjv4dq5avm wbrrl9
20 Jun 16
ImmunoGen Announces Pricing of $100 Million Offering of 4.50% Convertible Senior Notes Due 2021
12:00am
8-K
rhwsur
13 Jun 16
Immunogen Announces Proposed $100 Million Offering of Convertible Senior Notes Due 2021
12:00am
8-K
seb fl8v4
29 Apr 16
ImmunoGen Reports Third Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update
12:00am
8-K
yy8am6z3338t09 4nzu
26 Apr 16
Departure of Directors or Certain Officers
12:00am
8-K
eu6ec jfwn8
5 Apr 16
Departure of Directors or Certain Officers
12:00am
8-K
oe2sjsw3qj
29 Jan 16
ImmunoGen Reports Second Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update
12:00am
8-K
krwhe2x k0
26 Jan 16
Other Events
12:00am
8-K
rvone4m
11 Jan 16
ImmunoGen Announces Recent Product Program Advancements and Anticipated 2016 Events in Advance of J.P. Morgan Healthcare Conference
12:00am
8-K
2vd6h oeoa8r8s
12 Nov 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
8reznmc hs5cayz6cb
27 Oct 15
ImmunoGen Reports First Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update
12:00am
8-K
dea c7g9pqq15chm03t
22 Oct 15
Other Events
12:00am
8-K
dmal05ei6m5ql2c
31 Jul 15
ImmunoGen, Inc. Reports Fourth Quarter and Fiscal Year 2015 Financial Results
12:00am
8-K
7f89c il6h6jcu
2 Jun 15
Other Events
12:00am
8-K
quvxsokv7
1 Jun 15
Other Events
12:00am
8-K
c8s21zlchjwwxog
21 May 15
Other Events
12:00am